nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Editorial Board
|
|
|
2007 |
59 |
2-3 |
p. ii- 1 p. |
artikel |
2 |
Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides
|
Meade, Bryan R. |
|
2007 |
59 |
2-3 |
p. 134-140 7 p. |
artikel |
3 |
Gene manipulation through the use of small interfering RNA (siRNA): From in vitro to in vivo applications
|
Kumar, Lekha Dinesh |
|
2007 |
59 |
2-3 |
p. 87-100 14 p. |
artikel |
4 |
Non-viral siRNA delivery to the lung
|
Thomas, Mini |
|
2007 |
59 |
2-3 |
p. 124-133 10 p. |
artikel |
5 |
Opportunities and challenges for therapeutic gene silencing using RNAi and microRNA technologies
|
Akhtar, Saghir |
|
2007 |
59 |
2-3 |
p. 73-74 2 p. |
artikel |
6 |
RNA interference and innate immunity
|
Sioud, Mouldy |
|
2007 |
59 |
2-3 |
p. 153-163 11 p. |
artikel |
7 |
RNAi therapeutics: Principles, prospects and challenges
|
Aagaard, Lars |
|
2007 |
59 |
2-3 |
p. 75-86 12 p. |
artikel |
8 |
shRNA and siRNA delivery to the brain
|
Pardridge, William M. |
|
2007 |
59 |
2-3 |
p. 141-152 12 p. |
artikel |
9 |
Systemic siRNA delivery via hydrodynamic intravascular injection
|
Lewis, David L. |
|
2007 |
59 |
2-3 |
p. 115-123 9 p. |
artikel |
10 |
Therapeutic potential for microRNAs
|
Esau, Christine C. |
|
2007 |
59 |
2-3 |
p. 101-114 14 p. |
artikel |
11 |
Toxicogenomics of non-viral drug delivery systems for RNAi: Potential impact on siRNA-mediated gene silencing activity and specificity
|
Akhtar, Saghir |
|
2007 |
59 |
2-3 |
p. 164-182 19 p. |
artikel |